Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Covance Acquires Swiss Site | Contract Pharma
Breaking News

Covance Acquires Swiss Site

Covance is expanding its clinical pharmacology footprint in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical research company based in Basel, Switzerland.

Covance is expanding its clinical pharmacology footprint in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical research company based in Basel, Switzerland. The facility increases Covance’s global capacity to approximately 550 beds in the U.S. and Europe. The company’s staff includes nine physicians as well as other medical staff. All Swiss Pharma Contract employees will be offered employment at Covance.

Swiss Pharma Contract provides clinical research services to the pharmaceutical, biotechnology, and medical-device industries. The company has conducted more than 200 complex trials since 2002, with roughly a third of them being first-in-human studies. The Basel site also has expertise in radiolabeled and proof-of-concept studies, experience in specialty therapeutic areas, and access to a large volunteer database.

“Our clients’ need for complex, high-science clinical pharmacology studies that can help them make decisions faster is growing,” said Joe Herring, Covance chief executive officer. “This acquisition significantly increases Covance’s early clinical development footprint in Europe and gives our clients access to special patient populations for Phase I/IIa clinical studies. Covance’s early clinical development offerings are well-positioned to provide our clients with the knowledge critical to enhancing downstream success rates.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters